Exact Mass: 489.34877560000007
Exact Mass Matches: 489.34877560000007
Found 158 metabolites which its exact mass value is equals to given mass value 489.34877560000007,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Borrelidin
C28H43NO6 (489.30902180000004)
A macrolide that is isolated from several Streptomyces species and displays antibiotic, antineoplastic and antimalarial properties.
Chenodeoxycholylproline
Chenodeoxycholylproline belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholylproline consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Proline conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholylproline, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholylproline appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
Deoxycholylproline
Deoxycholylproline belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Deoxycholylproline consists of the bile acid deoxycholic acid conjugated to the amino acid Proline conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Deoxycholylproline, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Deoxycholylproline appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
Vertilmicin
Erucylphosphocholine
C27H56NO4P (489.3946746000001)
Nirogacestat
C27H41F2N5O (489.32790000000006)
D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators
N-(20-amino-4-hydroxy-4,8,12,17-tetraazaicosyl)-1H-indole-3-acetamide
N-(20-amino-4,8,12,17-tetraazaicosyl)-4-hydroxy-1H-indole-3-acetamide
Lys Lys Lys Ser
Lys Lys Ser Lys
Lys Ser Lys Lys
Ser Lys Lys Lys
2-pentacosanamidoethanesulfonic acid
C27H55NO4S (489.38515900000004)
Carboprost tromethamine
D012102 - Reproductive Control Agents > D010120 - Oxytocics C78568 - Prostaglandin Analogue
2-[bis(2-hydroxyethyl)amino]ethanol,4-tridecan-3-ylbenzenesulfonic acid
C25H47NO6S (489.31239220000003)
Nirogacestat
C27H41F2N5O (489.32790000000006)
D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators C471 - Enzyme Inhibitor
1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13E,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-Oate
(1R,2R)-2-[(4E,6Z,8R,9S,11R,13S,15S,16S)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclopentane-1-carboxylic acid
C28H43NO6 (489.30902180000004)
[(E)-docos-13-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C27H56NO4P (489.3946746000001)
(-)-borrelidin
C28H43NO6 (489.30902180000004)
(3R,9R,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one
[(1S)-1-(cyclopropylmethyl)-7-methoxy-2-[(2-methoxyphenyl)methyl]-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol
N-[(4S,7R,8S)-5-(cyclohexylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C27H43N3O5 (489.32025480000004)
N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-[[(3S)-5-methyl-2-oxohexan-3-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamic acid (phenylmethyl) ester
C27H43N3O5 (489.32025480000004)
(3R,9S,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one
(3R,9S,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C27H43N3O5 (489.32025480000004)
N-[(4S,7S,8S)-5-(cyclohexylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C27H43N3O5 (489.32025480000004)
N-[(4R,7R,8R)-5-(cyclohexylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C27H43N3O5 (489.32025480000004)
N-[(4R,7R,8S)-5-(cyclohexylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C27H43N3O5 (489.32025480000004)
(10R,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
(10S,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
(10S,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C27H43N3O5 (489.32025480000004)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C27H43N3O5 (489.32025480000004)
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C27H43N3O5 (489.32025480000004)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C27H43N3O5 (489.32025480000004)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C27H43N3O5 (489.32025480000004)
N-[(4S,7R,8R)-5-(cyclohexylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C27H43N3O5 (489.32025480000004)
N-[(4R,7S,8S)-5-(cyclohexylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C27H43N3O5 (489.32025480000004)
N-[(4S,7S,8R)-5-(cyclohexylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C27H43N3O5 (489.32025480000004)
N-[(4R,7S,8R)-5-(cyclohexylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C27H43N3O5 (489.32025480000004)
(10R,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
(10S,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
(10R,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
(10R,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
[(1R)-1-(cyclopropylmethyl)-7-methoxy-2-[(2-methoxyphenyl)methyl]-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol
2-aminoethyl [2-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propyl] hydrogen phosphate
(E)-3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]dec-4-ene-1-sulfonic acid
C25H47NO6S (489.31239220000003)
(E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]undec-4-ene-1-sulfonic acid
C25H47NO6S (489.31239220000003)
(4E,8E)-3-hydroxy-2-(2-hydroxydodecanoylamino)trideca-4,8-diene-1-sulfonic acid
C25H47NO6S (489.31239220000003)
(E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]dodec-4-ene-1-sulfonic acid
C25H47NO6S (489.31239220000003)
(4E,8E)-3-hydroxy-2-(2-hydroxytridecanoylamino)dodeca-4,8-diene-1-sulfonic acid
C25H47NO6S (489.31239220000003)
(E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]tridec-4-ene-1-sulfonic acid
C25H47NO6S (489.31239220000003)
3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]dodecane-1-sulfonic acid
C26H51NO5S (489.34877560000007)
(E)-3-hydroxy-2-(undecanoylamino)pentadec-4-ene-1-sulfonic acid
C26H51NO5S (489.34877560000007)
3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tridecane-1-sulfonic acid
C26H51NO5S (489.34877560000007)
(E)-3-hydroxy-2-(pentadecanoylamino)undec-4-ene-1-sulfonic acid
C26H51NO5S (489.34877560000007)
(E)-2-(decanoylamino)-3-hydroxyhexadec-4-ene-1-sulfonic acid
C26H51NO5S (489.34877560000007)
2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydecane-1-sulfonic acid
C26H51NO5S (489.34877560000007)
(E)-3-hydroxy-2-(tridecanoylamino)tridec-4-ene-1-sulfonic acid
C26H51NO5S (489.34877560000007)
(E)-3-hydroxy-2-(tetradecanoylamino)dodec-4-ene-1-sulfonic acid
C26H51NO5S (489.34877560000007)
(E)-2-(hexadecanoylamino)-3-hydroxydec-4-ene-1-sulfonic acid
C26H51NO5S (489.34877560000007)
(E)-2-(dodecanoylamino)-3-hydroxytetradec-4-ene-1-sulfonic acid
C26H51NO5S (489.34877560000007)
3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]undecane-1-sulfonic acid
C26H51NO5S (489.34877560000007)
2-[[(4E,8E,12E)-2-(butanoylamino)-3-hydroxypentadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)hexadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-acetamido-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
7-hydroxy-1-[1-(3-hydroxy-5-methylpiperidin-2-yl)ethyl]-9a,11a-dimethyl-6-oxo-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate
(2r)-2-(2-{[(3r,4r,5s,7s,16s)-17-amino-4,16-dihydroxy-3,7-dimethylheptadecan-5-yl]oxy}-2-oxoethyl)butanedioic acid
(1r,2r)-2-[(2s,4z,6e,8s,9s,11r,13s,15s,16s)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclopentane-1-carboxylic acid
C28H43NO6 (489.30902180000004)
2-[(3r,4as,8s,10ar,10bs)-7,7,10b-trimethyl-8-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-1h,2h,3h,4ah,5h,8h,9h,10h,10ah-naphtho[2,1-b]pyran-3-yl]propan-2-ol
n-[3-(17-amino-1-hydroxy-1,5,9,14-tetraazaheptadecan-1-yl)propyl]-2-(1h-indol-3-yl)ethanimidic acid
(1r,2r,3as,3br,5ar,7s,9ar,9bs,11as)-7-hydroxy-1-[(1s)-1-[(2r,3s,5r)-3-hydroxy-5-methylpiperidin-2-yl]ethyl]-9a,11a-dimethyl-6-oxo-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate
2-[(3s,4as,8s,10ar,10bs)-7,7,10b-trimethyl-8-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-1h,2h,3h,4ah,5h,8h,9h,10h,10ah-naphtho[2,1-b]pyran-3-yl]propan-2-ol
5-(1,2-dihydroxy-4-oxocyclohexyl)-3-[6-(4,6-dimethyloct-2-en-2-yl)-5-methyloxan-2-yl]-4-hydroxy-1-methylpyridin-2-one
C28H43NO6 (489.30902180000004)
(1s,2s)-2-[(2r,4z,6e,8s,9r,13r,15r,16r)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclopentane-1-carboxylic acid
C28H43NO6 (489.30902180000004)
(4s,5s,7s,9r,11s,12s,13e,15e,18s)-18-[(1r,2r)-2-carboxycyclopentyl]-4,12-dihydroxy-13-isocyano-5,7,9,11-tetramethyl-1-oxacyclooctadeca-13,15-dien-2-one
C28H43NO6 (489.30902180000004)
(1s,4s,7s)-9-{[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-6-hydroxy-4-isopropyl-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one
(2e)-1-[(8s)-13-carboximidoyl-6-hydroxy-8-phenyl-1,5,9,13-tetraazacycloheptadec-5-en-1-yl]-3-phenylprop-2-en-1-one
n-(20-amino-4,8,12,17-tetraazaicosan-1-yl)-2-(4-hydroxy-1h-indol-2-yl)ethanimidic acid
2-{2-[(17-amino-4,16-dihydroxy-3,7-dimethylheptadecan-5-yl)oxy]-2-oxoethyl}butanedioic acid
2-[(3s,4as,8s,10ar,10bs)-7,7,10b-trimethyl-8-{[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl}-1h,2h,3h,4ah,5h,8h,9h,10h,10ah-naphtho[2,1-b]pyran-3-yl]propan-2-ol
n-[3-(17-amino-1-hydroxy-1,5,9,14-tetraazaheptadecan-1-yl)propyl]-2-(1h-indol-2-yl)ethanimidic acid
5-[(1s,2r)-1,2-dihydroxy-4-oxocyclohexyl]-3-[(2s,5r,6r)-6-[(2z)-4,6-dimethyloct-2-en-2-yl]-5-methyloxan-2-yl]-4-hydroxy-1-methylpyridin-2-one
C28H43NO6 (489.30902180000004)
5-[(1s,2r)-1,2-dihydroxy-4-oxocyclohexyl]-3-[(2s,5r,6r)-6-[(2e,4r,6s)-4,6-dimethyloct-2-en-2-yl]-5-methyloxan-2-yl]-4-hydroxy-1-methylpyridin-2-one
C28H43NO6 (489.30902180000004)
2-(7,7,10b-trimethyl-8-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-1h,2h,3h,4ah,5h,8h,9h,10h,10ah-naphtho[2,1-b]pyran-3-yl)propan-2-ol
5-(1,2-dihydroxy-4-oxocyclohexyl)-3-{6-[(2z)-4,6-dimethyloct-2-en-2-yl]-5-methyloxan-2-yl}-4-hydroxy-1-methylpyridin-2-one
C28H43NO6 (489.30902180000004)
(3s,6r)-3-{[5,7-bis(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-isopropyl-3,6-dihydropyrazine-2,5-diol
(2z)-1-[(8s)-13-carboximidoyl-6-hydroxy-8-phenyl-1,5,9,13-tetraazacycloheptadec-5-en-1-yl]-3-phenylprop-2-en-1-one
3-{[5,7-bis(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-isopropyl-3,6-dihydropyrazine-2,5-diol
2-(7,7,10b-trimethyl-8-{[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl}-1h,2h,3h,4ah,5h,8h,9h,10h,10ah-naphtho[2,1-b]pyran-3-yl)propan-2-ol
1-(13-carboximidoyl-6-hydroxy-8-phenyl-1,5,9,13-tetraazacycloheptadec-5-en-1-yl)-3-phenylprop-2-en-1-one
(1r,2r,3ar,3br,5ar,7s,9ar,9br,11as)-7-hydroxy-1-[(1s)-1-[(2r,3s,5r)-3-hydroxy-5-methylpiperidin-2-yl]ethyl]-9a,11a-dimethyl-6-oxo-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate
5-[(1s,2s)-1,2-dihydroxy-4-oxocyclohexyl]-3-[(2s,5r,6r)-6-[(2e,4r,6s)-4,6-dimethyloct-2-en-2-yl]-5-methyloxan-2-yl]-4-hydroxy-1-methylpyridin-2-one
C28H43NO6 (489.30902180000004)
(1s)-2-[(2r,4e,6z,8s,9s,11s,13r,15r,16r)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclopentane-1-carboxylic acid
C28H43NO6 (489.30902180000004)
(2s,3r,11bs)-3-ethyl-9,10-dimethoxy-2-{[(1r)-6-methoxy-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinoline
(1r,2r)-2-[(2s,8s,9s,11r,13s,15s,16s)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclopentane-1-carboxylic acid
C28H43NO6 (489.30902180000004)
(1r,2r)-2-[(2s,4e,6z,8s,9s,11r,13s,15s,16s)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclopentane-1-carboxylic acid
C28H43NO6 (489.30902180000004)
5-[(1s,2r)-1,2-dihydroxy-4-oxocyclohexyl]-3-[(2s,5r,6r)-6-[(2e)-4,6-dimethyloct-2-en-2-yl]-5-methyloxan-2-yl]-4-hydroxy-1-methylpyridin-2-one
C28H43NO6 (489.30902180000004)
5-[(1s,2s)-1,2-dihydroxy-4-oxocyclohexyl]-3-[(2s,5r,6r)-6-[(2e,4s,6r)-4,6-dimethyloct-2-en-2-yl]-5-methyloxan-2-yl]-4-hydroxy-1-methylpyridin-2-one
C28H43NO6 (489.30902180000004)
5-[(1s,2r)-1,2-dihydroxy-4-oxocyclohexyl]-3-[(2s,5r,6r)-6-[(2e,4s,6s)-4,6-dimethyloct-2-en-2-yl]-5-methyloxan-2-yl]-4-hydroxy-1-methylpyridin-2-one
C28H43NO6 (489.30902180000004)
(2s,5s,6r,10r,11s)-5-benzyl-10-heptyl-6-hydroxy-2-isopropyl-4,11-dimethyl-1,9-dioxa-4-azacyclododecane-3,8,12-trione
C28H43NO6 (489.30902180000004)
2-(7,7a,10b-trimethyl-8-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-1h,2h,3h,4ah,5h,8h,9h,10h,10ah-azuleno[5,4-b]pyran-3-yl)propan-2-ol
(1r,2r)-2-[(2s,4z,6e,8r,9s,11r,13s,15s,16s)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclopentane-1-carboxylic acid
C28H43NO6 (489.30902180000004)
2-[(3r,4ar,7ar,8r,10as,10br)-7,7a,10b-trimethyl-8-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-1h,2h,3h,4ah,5h,8h,9h,10h,10ah-azuleno[5,4-b]pyran-3-yl]propan-2-ol
5-benzyl-10-heptyl-6-hydroxy-2-isopropyl-4,11-dimethyl-1,9-dioxa-4-azacyclododecane-3,8,12-trione
C28H43NO6 (489.30902180000004)
5-[(1r,2r)-1,2-dihydroxy-4-oxocyclohexyl]-3-[(2r,5s,6s)-6-[(2e,4r,6s)-4,6-dimethyloct-2-en-2-yl]-5-methyloxan-2-yl]-4-hydroxy-1-methylpyridin-2-one
C28H43NO6 (489.30902180000004)